scholarly article | Q13442814 |
P50 | author | Joakim S Dahlin | Q59677319 |
Maria Ekoff | Q79984795 | ||
Mattias Mattsson | Q85925915 | ||
Rose-Marie Amini | Q89897297 | ||
Elin Rönnberg | Q91095166 | ||
Jennine Grootens | Q91886703 | ||
Johanna Ungerstedt | Q92343190 | ||
Gunnar Nilsson | Q42715569 | ||
P2093 | author name string | Michel Arock | |
Monika Klimkowska | |||
Stina Söderlund | |||
P2860 | cites work | Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. | Q54447022 |
Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells | Q58751494 | ||
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients | Q61818977 | ||
Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia | Q64008436 | ||
Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin | Q70410812 | ||
Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia | Q73668248 | ||
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene | Q74389155 | ||
Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis | Q77603880 | ||
Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood | Q24656265 | ||
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis | Q26830207 | ||
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Q27853375 | ||
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder | Q33784323 | ||
Prospective isolation of human clonogenic common myeloid progenitors | Q34154606 | ||
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow | Q35161508 | ||
Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay | Q35757696 | ||
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand | Q36070756 | ||
Lin- CD34hi CD117int/hi FcεRI+ cells in human blood constitute a rare population of mast cell progenitors | Q36517272 | ||
Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin | Q36822416 | ||
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria | Q36835061 | ||
Mast cell progenitors: origin, development and migration to tissues | Q38193606 | ||
The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis | Q38266219 | ||
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts | Q38777126 | ||
CD52 is a molecular target in advanced systemic mastocytosis. | Q39001575 | ||
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection | Q39010730 | ||
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis | Q39615506 | ||
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene | Q40678754 | ||
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event. | Q41612115 | ||
Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells | Q42814084 | ||
Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells | Q42823748 | ||
Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature | Q44438236 | ||
KIT signaling is dispensable for human mast cell progenitor development | Q45085248 | ||
Revision of the human hematopoietic tree: granulocyte subtypes derive from distinct hematopoietic lineages. | Q45899964 | ||
Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). | Q48013095 | ||
Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination. | Q50056845 | ||
Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. | Q50676184 | ||
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture | Q50789055 | ||
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications. | Q50900052 | ||
Detection of circulating mast cells in advanced systemic mastocytosis. | Q51530011 | ||
Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. | Q51906537 | ||
Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion. | Q53093872 | ||
Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry. | Q54284130 | ||
P921 | main subject | systemic mastocytosis | Q3851644 |
P304 | page(s) | 150-158 | |
P577 | publication date | 2019-04-08 | |
P1433 | published in | EBioMedicine | Q24912341 |
P1476 | title | Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis | |
P478 | volume | 43 |
Search more.